Bioequivalence of amoxicillin and clavulanic acid tablets in healthy volunteers
Zhang Gui
Abstract
Zhang Gui
Abstract
Objective:To study the relative bioequivalence of domestic and imported amoxicillin and clavulanic acid tablets.Methods:The randomized and crossover study was conducted in 10 healthy male volunteers.After a single dose of the drugs their plasma drug concentration was determined by microbiological assay.Results:Both the domestic and imported tablets of amoxicillin and clavulanic acid fitted to one compartment model.The pharmacokinetics parameters obtained were:C max =(5.17± 0.45 )mg/L,T max =(1.05±0.16)h,t 1/2 =(1.16±0.17)h,AUC 0~t =(12.89±1.03)(mg·h)/L for domestic amoxicillin;C max =(5.25±0.46)mg/L,T max =(1.08±0.23)h,t 1/2 =(1.37±0.23)h,AUC 0~t =(13.54±0.59)(mg·h)/L for imported amoxicillin;C max =(3.94±0.52)mg/L,T max = (1.10± 0.21)h,t 1/2 =(0.98±0.11)h,AUC 0~t =(8.25±0.92)(mg·h)/L for domestic clavulanic acid;C max =(4.10±0.35)mg/L,T max =(1.03±0.10)h,t 1/2 =(1.01±0.14)h,AUC 0~t =(8.18± 0.51) (mg·h)/L for imported clavulanic acid.The relative bioequivalence was:(95.3±7.3)% for amoxicillin;(100.6±6.0)% for clavulanic acid.Conclusion:The domestic and imported amoxicillin and clavulanic acid tablets are bioequivalence.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the relative bioequivalence of domestic and imported amoxicillin and clavulanic acid tablets.Methods:The randomized and crossover study was conducted in 10 healthy male volunteers.After a single dose of the drugs their plasma drug concentration was determined by microbiological assay.Results:Both the domestic and imported tablets of amoxicillin and clavulanic acid fitted to one compartment model.The pharmacokinetics parameters obtained were:C max =(5.17± 0.45 )mg/L,T max =(1.05±0.16)h,t 1/2 =(1.16±0.17)h,AUC 0~t =(12.89±1.03)(mg·h)/L for domestic amoxicillin;C max =(5.25±0.46)mg/L,T max =(1.08±0.23)h,t 1/2 =(1.37±0.23)h,AUC 0~t =(13.54±0.59)(mg·h)/L for imported amoxicillin;C max =(3.94±0.52)mg/L,T max = (1.10± 0.21)h,t 1/2 =(0.98±0.11)h,AUC 0~t =(8.25±0.92)(mg·h)/L for domestic clavulanic acid;C max =(4.10±0.35)mg/L,T max =(1.03±0.10)h,t 1/2 =(1.01±0.14)h,AUC 0~t =(8.18± 0.51) (mg·h)/L for imported clavulanic acid.The relative bioequivalence was:(95.3±7.3)% for amoxicillin;(100.6±6.0)% for clavulanic acid.Conclusion:The domestic and imported amoxicillin and clavulanic acid tablets are bioequivalence.
Key concepts: Bioequivalence, Clavulanic acid, Amoxicillin, Pharmacokinetics, Pharmacology, Crossover study, Medicine, Antibacterial agent